Siglec-1-targeting single domain antibodies block or enhance pathogen binding to dendritic cells. [PDF]
Brink HJ +24 more
europepmc +1 more source
Siglec-15 promotes a feed-forward loop between TNBC cells and macrophages via the NF-κB/DcR3/CCL18/STAT3 axis. [PDF]
Wang S +5 more
europepmc +1 more source
Targeting inhibitory phagocytosis checkpoints in cancer immunotherapy: mechanisms, therapeutic strategies, and translational challenges. [PDF]
Li J +10 more
europepmc +1 more source
Siglec-15 Expression in Gastric Carcinoma and Its Association With Clinicopathological Variables. [PDF]
Al Badr S +5 more
europepmc +1 more source
Glycosylation converts CD24 from a developmental marker into a glyco-immune checkpoint in B-cell acute lymphoblastic leukemia. [PDF]
Yan S, Zhang X.
europepmc +1 more source
Association between DPAGT1 and Siglec-15 expression and the malignant phenotype of hepatocellular carcinoma. [PDF]
Luo M +5 more
europepmc +1 more source
Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy. [PDF]
Guo Z +12 more
europepmc +1 more source
Subcellular Localization of CD24 Is Associated with Integrin β1 Signaling, Immune Suppression, and Clinical Outcomes Across Human Cancers. [PDF]
Patel B +4 more
europepmc +1 more source
Spatio-controlled sialic acid polymer molecular patterns for selective Siglecs modulation and cytokine storm abrogation. [PDF]
Cao Y +15 more
europepmc +1 more source
Exploring the Binding Specificity of Siglec-Derived Peptides to Human Primary Amine Oxidase Using an Integrative Approach to Ligand Epitope Mapping. [PDF]
Alix M +6 more
europepmc +1 more source

